Diagnosed with an MPN? Consider a Second Opinion and See an Expert!
Being seen by a physician that is both an expert in a specific condition and getting an "in person" second opinion from that physician are often essential to receiving the best care.
Because Myeloproliferative Neoplasms (MPN) are uncommon and treatment is evolving it is important to find physicians who have experience and are focused on improving treatment. In the United States there are physicians dedicated to advancing the treatment of Polycythemia, Myelofibrosis, and Essential Thrombocythemia. Patients should at least consider getting an “in person” second opinion by one of these experts.
The physicians listed below all have expertise in managing MPN's and are the ones most likely to be performing clinical trials which are an important component of moving MPN treatment forward. Click here to learn more about second opinions.
Arkansas
- Kamal Patel MD – Carti Cancer Center
Arizona
- John Camoriano MD – Mayo Clinic
- Jeanne Palmer MD
- Krisstina Gowin DO - University of Arizona
California
- Solomon Hamburg MD - UCLA
- Michael Rosove MD - UCLA
- Casey O’Connell MD – Keck USC
- David Leibowitz MD – Sutter Health
- Catriona Jamieson MD – UC San Diego Moores Cancer Center
- Jason Gotlib MD - Stanford University Cancer Center, Palo Alto
- Lloyd Damon MD - University of California, San Francisco (San Francisco, CA)·
Connecticut
- Nikolai Podoltsev MD – Yale Cancer Center
Colorado
- Brandon McMahon MD
- Daniel Pollyea MD - University of Colorado Cancer Center – Anschutz (Aurora, Colorado)
Florida
- Candido Rivera MD - Mayo Clinic (Jacksonville, FL)
- Rami Komrokji MD - Lee Moffitt Cancer Center and Research Institute
- Kendra Sweet MD
- Andrew Kuykendall MD
- Chieh-Lin Fu MD
Georgia
- Elliot Winton MD - Georgia Cancer Emory Winship Cancer Institute (Atlanta)
- Rebecca Klisovic MD
Illinois
- Robert E. Lurie- Comprehensive Cancer Center at Northwestern University in Chicago
Indiana
- Larry Cripe MD – Indiana University
- Jamile Shammo MD - Rush University
- Brady Stein MD - Northwestern
Kansas
- Abdulraheem Yacoub MD - University of Kansas Cancer Center
Maryland
- Alison Moliterno MD - Johns Hopkins (Baltimore, MD)
- Jerry Spivak MD
- Evan Braunstein MD
- Maria Baer MD – University of Maryland
Massachusetts
- Ann Mullally MD - Dana Farber Cancer Institute (Boston, Massachusetts)
- Eric Winer MD
- Richard Stone MD
- Marlise Luskin MD
- Jonathan Gerber MD – Univ of Massachusetts
Relatlimab Anti-LAG-3 Antibody
Is combination immunotherapy with the anti-LAG-3 antibody relatlimab and Opdivo the next advance in melanoma treatment?
Blood Cancers and COVID-19 - What You Need to Know
COCID-19 puts individuals with leukemia, lymphoma, myeloma and MPN's at risk - learn how to optimize your care.
Michigan
- Moshe Talpaz MD - University of Michigan Comprehensive Cancer Center (Ann Arbor, Michigan)
- Kristen Marie Pettit MD
Minnesota
- Ayalew Tefferi MD – Mayo Clinic
- Christopher Cook MD
- Animesh Pardanani MD
- Alexandra Wolansky-Spinner MD -University of Minnesota Cancer Center (Minneapolis, MN)
Missouri
- Steven T. Oh MD - Siteman Cancer Center/Barnes Jewish Hospital/Washington University School of Medicine in St Louis
New Jersey
New York
- Eunice Wang - Roswell Park Cancer Institute in Buffalo
- Raajit Rampal MD - Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City
- Michael Mauro MD
- Martin Tallman MD
- Ronald Hoffman MD – Mount Sinai
- Mark Heaney MD – Columbia University
- Ellen Ritchie MD – NY Presbyterian-Weill Cornell Medical Center
- Marina Kremyanskaya MD
- Michael Samuel MD
- Andrew Schafer MD
North Carolina
- Lindsay Rein MD - Duke Health
- Harry Erba MD
- Brandi Reeves MD – UNC Hospital
- Dimitry Berenzon MD – Wake Forrest Baptist Health
Ohio
Aaron T Gerds MD - The Cleveland Clinic Taussig Cancer Center Sarcoma Page (Cleveland, Ohio)
Oregon
Pennsylvania
- Elizabeth Hexner MD - Abramson Cancer Center Pennsylvania Hospital (Philadelphia, PA)
- James Rossetti MD – Hillman Cancer Center
- Salman Fazal MD – Allegheny Health Network
South Carolina
- Suzanne Fanning MD – GHS Cancer Institute
Tennessee
- Michael Savona – Vanderbilt, Nashville
- Sanjay Mohan
Texas
- Srdan Verstovsek MD - M.D.Anderson Cancer Center (MDACC) (Houston, Texas)
- Prithviraj Bose MD
- Naveen Pemmaraju MD
- Ruben Mesa MD – UT Health San Antonio Cancer Center
- Scott Ulmer MD – Start Center for Cancer Care
Utah
- Michael Deininger MD – Huntsman Cancer Institute
- Josef Prchal MD
- Tswant Tashi MD
Virginia
- Firas El Chaer MD – UVA, Emily Couric Clinical Cancer Center
Washington
- Joachim Deeg MD – Fred Hutchinson Cancer Center
- Bart Scott MD - Seattle Cancer Care Alliance (Seattle, Washington)
Wisconsin
- Laura Michaelis MD – Froedtert & The Medical College of Wisconsin Clinical Cancer Center (Milwaukee)
